{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:02:08Z","timestamp":1758704528507,"version":"3.44.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaad.2025.03.058","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T20:54:22Z","timestamp":1742849662000},"page":"e53-e54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Response to the article by Lai et al. \u201cComment on Ormaza Vera et al. \u2018Interleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic na\u00efve patients with psoriasis: A retrospective cohort study\u2019\u201d"],"prefix":"10.1016","volume":"93","author":[{"given":"Ana","family":"Ormaza Vera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6783-1904","authenticated-orcid":false,"given":"Clinton W.","family":"Enos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2025.03.058_bib1","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jaad.2024.12.054","article-title":"Comment on Ormaza Vera et al\u2019s. \u201cInterleuking 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic-na\u00efve patients with psoriasis: a retrospective cohort study.\u201d","volume":"93","author":"Lai","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.03.058_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaad.2024.09.063","article-title":"Interleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared with biologic-naive patients with psoriasis: a retrospective cohort study","volume":"92","author":"Ormaza Vera","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.03.058_bib3","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20f13681","article-title":"Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets","volume":"81","author":"Andrade","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2025.03.058_bib4","article-title":"Data from: supplemental data for JAAD manuscript titled: \u201cInterleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic na\u00efve patients with psoriasis: a retrospective cohort study.\u201d","volume":"V1","author":"Ormaza Vera","year":"2024","journal-title":"Mendeley Data"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225005286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225005286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T20:39:08Z","timestamp":1758659948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225005286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0190962225005286"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.03.058","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to the article by Lai et al. \u201cComment on Ormaza Vera et al. \u2018Interleukin-23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic na\u00efve patients with psoriasis: A retrospective cohort study\u2019\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.03.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.12.054","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}